Logo

Jay Moyes, Lynda Merrill

May 20, 2008
Premium
Jay Moyes has become chief financial officer of XDx, the molecular diagnostics company said this week. Most recently, he was vice president of finance and CFO at Myriad Genetics. Prior to that, he served as CFO of Genmark, an agricultural biotechnology company. Moyes holds an MBA from the University of Utah and a BA in economics from Weber State University.
 
 

Lynda Merrill has joined Qiagen as vice president of molecular diagnostics sales for Europe, Middle East, Africa, and Australia, the company said last week. Merrill, who is based in the UK, formerly was a vice president at Gen-Probe and served in management roles at Boehringer Mannheim.

Filed under

Clinical Sequencing
Sequencing
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.